Effects of Hallucinogens and Other Drugs on Mood and Performance

Brief Summary

This non-treatment study will investigate the effects on mood and performance caused by hallucinogens and other psychoactive compounds.

Intervention / Treatment

  • Drug: Hallucinogens and psychoactive substances

Condition or Disease

  • Healthy

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 21 Years to 50 Years   (Adult)
Enrollment: 20 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Apr 01, 2014
Primary Completion: Feb 01, 2019
Completion Date: Feb 01, 2019
Study First Posted: Jan 13, 2014
Results First Posted: Aug 31, 2020
Last Updated: May 16, 2019

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Twenty volunteers between 21-50 years old will each participate in 16 total sessions, including sessions for: screening, preparation, experiment/drug, immediate follow-ups, a 1-month follow-up and 1 post completion urine collection. On each of five experimental session participants will orally ingest capsules of either a placebo or varying doses of one of 18 different psychoactive compounds.

Subjective drug effects will be examined with methods previously used by this laboratory for characterizing the effects of psychoactive substances from a variety different classes. Volunteers will swallow capsules containing various doses of drugs, complete tasks during the session, and rate effects of the drug and complete questionnaires at the end of each session as described below.

Eligibility Criteria

Sex: All
Minimum Age: 21
Maximum Age: 50

More Details

NCT Number: NCT02033707
Other IDs: NA_00082804
Study URL: https://ClinicalTrials.gov/show/NCT02033707
Last updated: Jun 16, 2022